Literature DB >> 33156902

Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality.

Teresa K Chen1,2, Michelle M Estrella3, Lawrence J Appel2,4,5, Josef Coresh2,4,5, Shengyuan Luo6, Wassim Obeid1, Chirag R Parikh1,2,5, Morgan E Grams1,2,5.   

Abstract

Entities:  

Year:  2021        PMID： 33156902     DOI： 10.1093/ndt/gfaa260

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis.

Authors:  Jong-Joo Moon; Yejin Choi; Kyu-Hyeon Kim; Areum Seo; Soie Kwon; Yong-Chul Kim; Dong-Ki Kim; Yon-Su Kim; Seung-Hee Yang
Journal:  Biomedicines       Date:  2022-06-07

2.  Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease.

Authors:  Carolina Lopez-Silva; Aditya Surapaneni; Josef Coresh; Jochen Reiser; Chirag R Parikh; Wassim Obeid; Morgan E Grams; Teresa K Chen
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-23       Impact factor: 10.614

3.  Inflammatory response and matrix metalloproteinases in chronic kidney failure: Modulation by adropin and spexin.

Authors:  Burak Yazgan; Filiz Avcı; Gülsün Memi; Ebru Tastekin
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.